Natixis Advisors LLC boosted its position in Novanta Inc. (NASDAQ:NOVT – Free Report) by 159.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,921 shares of the technology company’s stock after buying an additional 23,332 shares during the period. Natixis Advisors LLC’s holdings in Novanta were worth $4,512,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in NOVT. AQR Capital Management LLC increased its position in Novanta by 78.9% in the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock valued at $537,000 after buying an additional 1,866 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in Novanta by 1.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock worth $53,582,000 after purchasing an additional 6,533 shares in the last quarter. Jane Street Group LLC increased its holdings in Novanta by 1,762.5% during the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock worth $7,881,000 after purchasing an additional 58,322 shares in the last quarter. First Trust Advisors LP bought a new stake in Novanta during the 2nd quarter worth approximately $528,000. Finally, Amundi increased its holdings in Novanta by 2.0% during the 2nd quarter. Amundi now owns 18,042 shares of the technology company’s stock worth $2,397,000 after purchasing an additional 347 shares in the last quarter. 98.35% of the stock is owned by institutional investors.
Insider Activity at Novanta
In related news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total value of $1,128,225.00. Following the transaction, the chief executive officer owned 42,761 shares in the company, valued at approximately $6,432,537.23. This represents a 14.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Buckley sold 9,957 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the completion of the transaction, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 23,957 shares of company stock worth $3,136,229. 1.20% of the stock is owned by company insiders.
Novanta Stock Performance
Novanta (NASDAQ:NOVT – Get Free Report) last released its earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.03. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The company had revenue of $257.71 million during the quarter, compared to analyst estimates of $253.40 million. During the same period in the prior year, the company posted $0.74 earnings per share. Novanta’s quarterly revenue was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, sell-side analysts expect that Novanta Inc. will post 3.59 earnings per share for the current year.
Analysts Set New Price Targets
NOVT has been the subject of a number of recent research reports. Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a report on Friday, April 17th. Finally, Robert W. Baird boosted their price objective on Novanta from $144.00 to $173.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Novanta has a consensus rating of “Hold” and an average target price of $173.00.
Check Out Our Latest Stock Report on NOVT
About Novanta
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Articles
- Five stocks we like better than Novanta
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
